These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 22728445)

  • 1. Molecular recognition in the human immunodeficiency virus capsid and antiviral design.
    Bocanegra R; Rodríguez-Huete A; Fuertes MÁ; Del Álamo M; Mateu MG
    Virus Res; 2012 Nov; 169(2):388-410. PubMed ID: 22728445
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of virtual screening for discovering antiretroviral compounds interacting with the HIV-1 nucleocapsid protein.
    Mori M; Schult-Dietrich P; Szafarowicz B; Humbert N; Debaene F; Sanglier-Cianferani S; Dietrich U; Mély Y; Botta M
    Virus Res; 2012 Nov; 169(2):377-87. PubMed ID: 22634301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The capsid protein of human immunodeficiency virus: designing inhibitors of capsid assembly.
    Neira JL
    FEBS J; 2009 Nov; 276(21):6110-7. PubMed ID: 19825045
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of dual inhibitors targeting both HIV-1 capsid and human cyclophilin A to inhibit the assembly and uncoating of the viral capsid.
    Li J; Tan Z; Tang S; Hewlett I; Pang R; He M; He S; Tian B; Chen K; Yang M
    Bioorg Med Chem; 2009 Apr; 17(8):3177-88. PubMed ID: 19328002
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Comparative evaluation of Hebei HIV-1 p24 kit for the detection of human immunodeficiency virus].
    Yang YS; Wang RT; Zhang XG; Zhang HZ; Wang HF; Li ZL; Zeng Y
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2007 Mar; 21(1):8-10. PubMed ID: 17429521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A mammalian two-hybrid system-based assay for small-molecular HIV fusion inhibitors targeting gp41.
    Shui X; Lu X; Gao Y; Liu C; Ren F; Jiang Q; Zhang H; Zhao B; Zheng Z
    Antiviral Res; 2011 Apr; 90(1):54-63. PubMed ID: 21352856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular strategies to design an escape-proof antiviral therapy.
    Berkhout B; Sanders RW
    Antiviral Res; 2011 Oct; 92(1):7-14. PubMed ID: 21513746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complementary Assays Reveal a Low Level of CA Associated with Viral Complexes in the Nuclei of HIV-1-Infected Cells.
    Hulme AE; Kelley Z; Foley D; Hope TJ
    J Virol; 2015 May; 89(10):5350-61. PubMed ID: 25741002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rationally designed interfacial peptides are efficient in vitro inhibitors of HIV-1 capsid assembly with antiviral activity.
    Bocanegra R; Nevot M; Doménech R; López I; Abián O; Rodríguez-Huete A; Cavasotto CN; Velázquez-Campoy A; Gómez J; Martínez MÁ; Neira JL; Mateu MG
    PLoS One; 2011; 6(9):e23877. PubMed ID: 21931621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification by high throughput screening of small compounds inhibiting the nucleic acid destabilization activity of the HIV-1 nucleocapsid protein.
    Shvadchak V; Sanglier S; Rocle S; Villa P; Haiech J; Hibert M; Van Dorsselaer A; Mély Y; de Rocquigny H
    Biochimie; 2009 Jul; 91(7):916-23. PubMed ID: 19401213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-throughput screening using pseudotyped lentiviral particles: a strategy for the identification of HIV-1 inhibitors in a cell-based assay.
    Garcia JM; Gao A; He PL; Choi J; Tang W; Bruzzone R; Schwartz O; Naya H; Nan FJ; Li J; Altmeyer R; Zuo JP
    Antiviral Res; 2009 Mar; 81(3):239-47. PubMed ID: 19118579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characteristics of a group of nonnucleoside reverse transcriptase inhibitors with structural diversity and potent anti-human immunodeficiency virus activity.
    Yang SS; Fliakas-Boltz V; Bader JP; Buckheit RW
    Leukemia; 1995 Oct; 9 Suppl 1():S75-85. PubMed ID: 7475321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein promiscuity: drug resistance and native functions--HIV-1 case.
    Fernández A; Tawfik DS; Berkhout B; Sanders R; Kloczkowski A; Sen T; Jernigan B
    J Biomol Struct Dyn; 2005 Jun; 22(6):615-24. PubMed ID: 15842167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potent inhibition of HIV-1 replication by backbone cyclic peptides bearing the Rev arginine rich motif.
    Chaloin L; Smagulova F; Hariton-Gazal E; Briant L; Loyter A; Devaux C
    J Biomed Sci; 2007 Sep; 14(5):565-84. PubMed ID: 17520355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel and efficient approach to discriminate between pre- and post-transcription HIV inhibitors.
    Daelemans D; Pannecouque C; Pavlakis GN; Tabarrini O; De Clercq E
    Mol Pharmacol; 2005 May; 67(5):1574-80. PubMed ID: 15728798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and antiviral activities of novel acylhydrazone derivatives targeting HIV-1 capsid protein.
    Tian B; He M; Tang S; Hewlett I; Tan Z; Li J; Jin Y; Yang M
    Bioorg Med Chem Lett; 2009 Apr; 19(8):2162-7. PubMed ID: 19297155
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dendrimers as potential inhibitors of the dimerization of the capsid protein of HIV-1.
    Doménech R; Abian O; Bocanegra R; Correa J; Sousa-Herves A; Riguera R; Mateu MG; Fernandez-Megia E; Velázquez-Campoy A; Neira JL
    Biomacromolecules; 2010 Aug; 11(8):2069-78. PubMed ID: 20690715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
    Van Vaerenbergh K
    Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A trimer of dimers is the basic building block for human immunodeficiency virus-1 capsid assembly.
    Tsiang M; Niedziela-Majka A; Hung M; Jin D; Hu E; Yant S; Samuel D; Liu X; Sakowicz R
    Biochemistry; 2012 Jun; 51(22):4416-28. PubMed ID: 22564075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specific Inhibitors of HIV Capsid Assembly Binding to the C-Terminal Domain of the Capsid Protein: Evaluation of 2-Arylquinazolines as Potential Antiviral Compounds.
    Machara A; Lux V; Kožíšek M; Grantz Šašková K; Štěpánek O; Kotora M; Parkan K; Pávová M; Glass B; Sehr P; Lewis J; Müller B; Kräusslich HG; Konvalinka J
    J Med Chem; 2016 Jan; 59(2):545-58. PubMed ID: 26685880
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.